C07K 2317/23
From birds
Official title: from birds
C07K2317/23 (From birds) appears on 216 US grants and 329 published applications in this corpus.
Search patents in C07K- Granted patents
- 216
- Published applications
- 329
- Assignees
- 184
- Inventors
- 630
- Latest grant
- 24 Mar 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1988 | 1 | 0 |
| 1989 | 0 | 0 |
| 1990 | 0 | 0 |
| 1991 | 2 | 0 |
| 1992 | 0 | 0 |
| 1993 | 1 | 0 |
| 1994 | 0 | 0 |
| 1995 | 0 | 0 |
| 1996 | 1 | 0 |
| 1997 | 0 | 0 |
| 1998 | 3 | 0 |
| 1999 | 3 | 0 |
| 2000 | 2 | 0 |
| 2001 | 3 | 0 |
| 2002 | 9 | 13 |
| 2003 | 7 | 10 |
| 2004 | 4 | 17 |
| 2005 | 3 | 12 |
| 2006 | 4 | 11 |
| 2007 | 9 | 12 |
| 2008 | 6 | 18 |
| 2009 | 12 | 12 |
| 2010 | 10 | 16 |
| 2011 | 10 | 17 |
| 2012 | 10 | 11 |
| 2013 | 7 | 8 |
| 2014 | 13 | 17 |
| 2015 | 4 | 13 |
| 2016 | 11 | 14 |
| 2017 | 8 | 6 |
| 2018 | 11 | 10 |
| 2019 | 5 | 15 |
| 2020 | 8 | 9 |
| 2021 | 7 | 22 |
| 2022 | 11 | 14 |
| 2023 | 9 | 14 |
| 2024 | 3 | 9 |
| 2025 | 12 | 19 |
| 2026 | 7 | 10 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Targeted anti-SGLT1 avian IgY antibodies as treatment of pre-diabetes, type 2 diabetes and gestational diabetes24 Mar 2026US 12,583,921 B2Lay Sciences, Inc.
- Human glucose-dependent insulinotropic polypeptide receptor (GIPR) antibodies and methods of use thereof to inhibit GIP receptor and signaling24 Mar 2026US 12,583,930 B2Crystal Bioscience Inc.
- Mixed binding domains17 Mar 2026US 12,577,327 B2Merus N.V.
- Transgenic chicken having an endogenous immunoglobulin heavy chain gene in which the IgY CH1 coding sequence is functionally deleted10 Mar 2026US 12,568,940 B2Crystal Bioscience Inc.
- Ostrich antibody for bacterial infectious diseases3 Mar 2026US 12,564,624 B2Ostrich Pharma KK
- Coronavirus antibodies and therapeutic uses thereof30 Jul 2026US 2026/0217797 A1Takeda Pharmaceutical Company Limited
- Animal feed supplement30 Jul 2026US 2026/0217802 A1
- Antibody specifically binding to b7-h316 Jul 2026US 2026/0201038 A1Cellabmed Inc.
- Antibody binding to cd22, and bispecific antibody, chimeric antigen receptor and antibody-drug conjugate comprising same, and use thereof25 Jun 2026US 2026/0176354 A1The Asan Foundation
- Novel anti-pad2 antibody4 Jun 2026US 2026/0152572 A1Pharma Foods International Co., Ltd.
Most cited
By later US patents
- System and method for measuring animals128US 8,036,429 B22011
- Vaccine for clostridium botulinum neurotoxin107US 5,919,665 AOphidian Pharmaceuticals, Inc. · 1999
- Method of passive immunization of mammals using avian antibody105US 4,748,018 AStolle Research & Development Corporation · 1988
- Gene regulation in transgenic animals using a transposon-based vector105US 7,608,451 B2Board of Supervisors of Louisiana State University Mechanical College · 2009
- Antibodies associated with alterations in bone density88US 6,803,453 B1Darwin Discovery, Ltd. · 2004